Advanced Oncotherapy PLC Share Price London S.E.
Equities
GB00B16JQ761
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- GBX | - |
05-09 | Advanced Oncotherapy Delists from London Bourse Amid Financing Deal | MT |
05-03 | Advanced Oncotherapy financing talks continue, funds delayed | AN |
Sales 2020 | - | Sales 2021 | - | Capitalization | 172M 13.63B |
---|---|---|---|---|---|
Net income 2020 | -25M -1.99B | Net income 2021 | -29M -2.3B | EV / Sales 2020 | - |
Net Debt 2020 | 48.32M 3.84B | Net Debt 2021 | 49.09M 3.9B | EV / Sales 2021 | - |
P/E ratio 2020 |
-4.11
x | P/E ratio 2021 |
-4.93
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 52.47% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 26/08/14 | |
Director of Finance/CFO | - | 30/09/16 | |
Michael Sinclair
CHM | Chairman | 82 | 15/06/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lori Cross
BRD | Director/Board Member | 64 | 28/09/20 |
Michael Sinclair
CHM | Chairman | 82 | 15/06/06 |
Hans von Celsing
BRD | Director/Board Member | 74 | 25/01/17 |
1st Jan change | Capi. | |
---|---|---|
+12.06% | 225B | |
+12.07% | 186B | |
+13.88% | 135B | |
+27.12% | 107B | |
+0.91% | 63.56B | |
+6.74% | 51.32B | |
+13.39% | 51.04B | |
+8.81% | 43.3B | |
+4.14% | 36.99B |